For a biotech with an established commercial infrastructure, the most efficient growth strategy is to in-license late-stage or already-approved products. This leverages the existing sales force and operational teams to sell new products without adding significant overhead, maximizing operational efficiency and revenue.
In any complex project or deal, problems are inevitable. By adopting a mindset that expects the unexpected, leaders can frame these issues as anticipated 'wrinkles' rather than crises. This psychological shift prevents panic and keeps the team focused on finding solutions instead of dwelling on the problem.
Senior leaders, particularly women, can actively drive diversity in service industries like investment banking. By making diversity of thought a key criterion when selecting advisory teams, they use their position as clients to create a powerful incentive for banks to promote and staff diverse talent.
During difficult periods, such as a failed clinical trial, the worst action a company can take is to cease communication. Continuously talking to investors, even when the news is bad, maintains trust and demonstrates resilience. Transparency in tough times is crucial for long-term investor relationships.
Prioritize candidates who have navigated difficult situations. They learn more from tough times than from being at a constantly successful company where mistakes might be masked by overall growth. Adversity builds crucial problem-solving skills and resilience that are invaluable to a growing organization.
Effective fundraising isn't a single event but a process. By conducting regular 'non-deal roadshows,' you build investor confidence and prove management's ability to execute on promises over time. This makes the eventual request for capital much more likely to succeed because trust has already been established.